9th -
10th
September 2025
September 2025 | 
UK

Driving Innovation and Excellence in Viral Vector Manufacturing for Life-Changing Gene Therapies

9th -
10th
September 2025 | 
UK
📆 Add to Google Calendar
Presentation
0 +
Organisations
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies
0 +

CONCEPT

The Viral Vector Manufacturing Forum is a premier platform dedicated to addressing the critical challenges in the production of viral vectors, with a focus on AAV and lentiviral vectors—two of the most widely used delivery systems in gene therapy. As the demand for gene therapies continues to grow, the pressure on manufacturers to scale up production, enhance quality, and streamline processes has never been greater. This forum has been specifically designed to tackle these challenges head-on, providing a space for industry leaders, innovators, and stakeholders to collaborate, share insights, and develop strategies to accelerate advancements in viral vector manufacturing.

Manufacturing bottlenecks remain a significant hurdle in the journey to bring gene therapies to patients. From optimising vector design and upstream processes to addressing regulatory complexities and ensuring seamless scale-up, the forum will cover every aspect of viral vector production. The event aims to drive innovation and operational excellence by exploring the latest advancements in platform technologies, process intensification, and quality assurance.

This forum is not just an event—it is a mission-driven gathering focused on empowering the biopharmaceutical industry to meet the urgent demand for gene therapies by improving viral vector manufacturing. By fostering dialogue, sharing practical solutions, and showcasing emerging trends, the Viral Vector Manufacturing Forum helps bridge the gap between innovation and patient access, ultimately contributing to the delivery of life-changing therapies.

Join us to be part of this critical conversation and collaborate with global leaders who are shaping the future of gene therapy manufacturing. Together, we can overcome the challenges and drive the development of scalable, efficient, and high-quality viral vector production processes.

FEATURED CONTENT

Viral Vector Manufacturing Forum 2025
.
.
.
.
.
.
.
.

THANK YOU TO OUR SUPPORTING PARTNERS









DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

FEATURED CONTENT

#BUZZ ABOUT THE EVENT

Register Now. SAVE BIG!

Download Post Event Report Form

Download Participating Companies

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Attendee List

Download Prospectus Document Form

Brochure Form

Sponsorship Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Agenda Form

Apply For Speaking Opportunity

Download List of Biopharma Companies in Asia Brochure

Download Ebook

Download Ebook

VWSEA2024 Brochure

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter